Marijuana Stocks & Public Companies

Stocks & Public Company News

Impact of DOJ Announcement, Cole Memo Short-Lived for Most Marijuana Stocks

The third quarter was surprisingly lackluster for publicly traded cannabis companies, with most stocks failing to hold gains tied to a groundbreaking move by the Department of Justice in August. Six of 12 prominent cannabis and hemp-related stocks came in flat for the July-September period, while two fell. Just four rose in value.

Read More

Regulatory Group’s Warning About Marijuana Stock Scams Highlights Difficulties MMJ Investors Face

Attention investors: If you’re thinking about pumping money into cannabis stocks, be very, very careful. That’s the advice a self-regulatory agency for brokerage firms and exchange markets issued this week. In an alert to investors, the Financial Industry Regulatory Authority (or Finra) said that con artists are increasingly setting their sights on the medical marijuana industry by […]

Read More

Earnings Update: Mixed Quarterly Results for 2 Publicly Traded Medical Cannabis Companies

Two of the more prominent – and transparent – publicly traded companies in the medical cannabis industry released second-quarter financial data this week, offering up a mixed bag for investors. GrowLife Inc. and Medical Marijuana Inc. reported financial progress in several areas but experienced setbacks in others, reflecting the challenges public MMJ companies as a […]

Read More

Medical Cannabis Stocks Socked in Second Quarter as Public Firms Fail to Gain Traction

Medical marijuana stocks continued to struggle in the second quarter despite increasing optimism over the industry’s future, underscoring the risky nature of cannabis investments and the sector itself. The share price of nearly every publicly traded company involved in the cannabis space fell or was flat from April through June – with a handful of […]

Read More

GrowLife’s Acquisition Strategy Leads to Spike in Revenues, But Wider Net Loss, in Q1

GrowLife Inc., a publicly traded company that provides cultivation equipment and related technology to the medical marijuana industry, reported a sevenfold increase in revenues during the first quarter but also sunk deeper into the red mainly due to non-cash charges. Revenues soared to $760,709 during the first three months of the year vs. $91,809 in […]

Read More

Cannabinoid Research Firm Cannabis Science, Inc. Could Go Under

By Anne Holland  [Updated as of 4/25/12]  According to its annual 2012 report filed today, Cannabis Science, Inc. (PINK:CBIS), may be in danger of shutting its doors. The company’s Form 10-K stated, “At this time, our ability to generate any significant revenues continues to be uncertain. There is substantial doubt about our ability to continue […]

Read More

Cannabis Stocks Start First Quarter With a Bang, End With a Fizzle as Hype Subsides

Most publicly traded cannabis companies got off to an impressive start in 2013, posting steady gains in January and then soaring to 52-week highs in February when hype over the industry’s future reached a fever pitch. But the euphoria has faded, and the majority of marijuana-related stocks closed out the first quarter – which wrapped […]

Read More